📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults (2024)

First Author: Koychev I

Attributed to: MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2023-081401

Publication URI: http://dx.doi.org/10.1136/bmjopen-2023-081401

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 6